Skip to main content
. 2016 Feb 18;5(5):e1139662. doi: 10.1080/2162402X.2016.1139662

Figure 5.

Figure 5.

Impact of lenalidomide in vitro in patients with refractory multiple myeloma on the expression of T-cell markers. The plot shows the expression of CD45RA on CD8+ T-cells (in % of all CD8+ T cells) from patients with refractory MM analyzed by flow cytometry.